Skip to content

People with HIV/HCV co-infection at increased risk of kidney disease and bone disorders

African Americans taking ART have high incidence of illness associated with risk of cardiovascular disease

Co-morbidities are common and rising among people with HIV in the US

Xue Song, presenting at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

Eric Daar at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

French study reveals the growing complexity of medical needs as people with HIV age

Edouard Battegay speaking at HIV Glasgow. Image credit: HIV Drug Therapy Glasgow 2016

Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

Managing non-communicable diseases among people living with HIV

Poor kidney function associated with increased cardiovascular risk for people with HIV

Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most

Craig Wilson presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com